baber/WOPTO huggingface dataset:
Patent CA-3042686-A1 (CA)
Inventor: FREEMAN JENNY E
IPC: A61B5/00
Filed: 2017-11-02
Abstract: La présente invention concerne un système et un procédé de notation d'alerte précoce. Le système comprend un dispositif informatique, une pluralité de capteurs pour acquérir des signaux physiologiques provenant d'un patient, les capteurs étant fonctionnellement connectés au dispositif informatique, et au moins une alarme conçue pour émettre une alerte lorsqu'un score d'alerte précoce (EWS) dépasse un niveau prédéterminé. Le dispositif informatique reçoit les signaux physiologiques provenant des capteurs, analyse les signaux physiologiques, et sur la base des signaux analysés, calcule le score d'alerte précoce, et compare le score d'alerte précoce à des limites prédéterminées et, si le score est en dehors des limites, déclenche une alarme ou actionne ou modifie un traitement ou une intervention médicale.
Patent CA-3043658-A1 (CA)
Title: Thermoassociative and exchangeable copolymers, composition comprising same
Inventor: DEROUINEAU THIBAULT
IPC: C10M145/14
Filed: 2017-11-21
Abstract: Compositions resulting from the mixing of at least one copolymer A1, resulting from the copolymerisation of at least one monomer functionalised by diol functions with at least one styrenic monomer, and at least one compound A2 comprising at least two boronic ester functions. They have very varied rheological properties depending on the proportion of compounds A1 and A2 used. Composition resulting from the mixing of at least one lubricating oil with such a composition of associative and exchangeable polymers and use of this composition for lubricating a mechanical part.
Patent CA-3043824-A1 (CA)
Title: Coffee maker and frother
Inventor: BARDOT LAURENT
IPC: A47J31/20
Filed: 2019-05-21
Abstract: An appliance for making beverages has a French press style carafe and a base adapted to receive the carafe removably thereon. The carafe has a rotatable stirring blade. The base has a motor rotationally coupled to the stirring blade, a heater, and a resting surface in thermal communication with the heater. Energization of the motor causes stirring of the liquid in the pitcher and energization of the heater causes heating of the liquid in the pitcher.
Patent CA-3043881-A1 (CA)
Title: Cardiac valve delivery devices and systems
Inventor: GREGG PETER
IPC: A61F2/966
Filed: 2017-11-16
Abstract: A delivery device includes a handle, a central elongate member extending from the handle, a sheath configured to slide over and relative to the central elongate member, a distal tether retainer at a distal end of the central elongate member, a proximal tether restraining mechanism positioned along the central elongate member distal of the handle and proximal of the distal tether retainer, and a plurality of tethers. The tethers are configured to extend from the proximal tether restraining mechanism to the distal tether retainer.
Patent CA-3044029-A1 (CA)
Title: A secure element to protect transactions made by or within a vehicle
Inventor: KOEPPEL ADAM
IPC: G06Q20/38
Filed: 2019-05-22
Abstract: A device associated with a vehicle may receive a device identifier of a user device that is registered to an authorized user or user identification data associated with the authorized user.  The device may include a secure element, and may receive, from an infotainment system, payment information associated with a transaction for a service. The device may secure the payment information using an encryption technique that is to use a public key associated with the device identifier or the user identification data to encrypt the payment information. The device may provide the payment information to the infotainment system, which may provide the payment information to another device that is associated with an organization providing the particular service. The other device may use a private key to decrypt the payment information, process the payment information, and may perform actions relating to the service based on the payment information being successfully processed.
Patent CA-3047813-A1 (CA)
Title: Systeme et procede associes destines a la formation d'un emballage a chambres multiples
Inventor: JOHNSON THOMAS
IPC: C11D17/04
Filed: 2018-01-04
Abstract: La présente invention concerne un système et un procédé associés destinés à la formation d'un emballage à chambres multiples. Le système comprend une seule bande d'un matériau de film s'étendant dans une direction de la machine et définissant une pluralité de lignes latérales s'étendant de manière contiguë dans une direction transversale à la machine, orthogonale à la direction de la machine. Le système comprend également un agencement de formation conçu pour interagir avec la bande pour former des chambres le long d'une seconde ligne de la pluralité de lignes latérales dans la direction de la machine, un premier dispositif de remplissage conçu pour déposer une première substance dans une ou plusieurs des chambres formées de la seconde ligne et un premier mécanisme de pliage conçu pour former un pli entre les lignes latérales dans la direction de la machine de sorte qu'une première ligne de la pluralité de lignes latérales est dirigée pour recouvrir la ou les chambres formées de la seconde ligne.
Patent CA-3047921-A1 (CA)
Inventor: REGE AARTI
IPC: A61K8/27
Filed: 2017-08-11
Abstract: An oral care composition comprising zinc phosphate, sodium fluoride, stannous pyrophosphate, and an organic acid buffer system, as well as methods of using the same.
Patent CA-3048201-A1 (CA)
Inventor: KOROLUK DEVON C
IPC: E21B17/10
Filed: 2019-06-28
Abstract: A vacuum insulated tubing including an inner pipe, an outer pipe concentrically arranged about the inner pipe such that an annulus is defined between the inner and outer pipes. A vacuum is drawn within the annulus, and a hydrocarbon-based coating is applied to at least one of the surfaces of the inner pipe or one of the surfaces of the outer pipe to reduce a rate of hydrogen migration into the annulus.
Patent CA-3049051-A1 (CA)
Title: Resolving abstract anaphoric references in conversational systems using hierarchically stacked neural networks
Inventor: AGARWAL PUNEET
IPC: G06N3/02
Filed: 2019-07-10
Abstract: Conversational systems are required to be capable of handling more sophisticated interactions than providing factual answers only. Such interactions are handled by resolving abstract anaphoric references in conversational systems which includes antecedent fact references and posterior fact references. The present disclosure resolves abstract anaphoric references in conversational systems using hierarchically stacked neural networks. In the present disclosure, a deep hierarchical maxpool network based model is used to obtain a representation of each utterance received from users and a representation of one or more generated sequences of utterances. The obtained representations are further used to identify contextual dependencies with in the one or more generated sequences which helps in resolving abstract anaphoric references in conversational systems. Further, a response for an incoming sequence of utterances is retrieved based on classification of incoming sequence of utterances into one or more pre-created responses. The proposed model takes lesser time to retrain.
Patent CA-3052148-A1 (CA)
Title: In vivo drug delivery devices and methods for drug delivery
Inventor: LEE HEEJIN
IPC: A61K9/00
Filed: 2018-02-01
Abstract: Drug delivery devices and methods of administering drugs to patients are provided. A device (50) includes a reservoir (60) containing a drug (58). The reservoir (60) is defined by a wall (64) having a water-permeable portion, such that the water-permeable portion permits water to enter the device (50) and contact the drug (58). A restraining plug (56) closes off an opening of the device (50) such that transient microchannels (62) form between an elastic portion (54) of the device (50) and the restraining plug (56), upon the generation of a sufficient pressure within the reservoir (60), to release the drug (58) from the device (50). Methods of treating patients for neurogenic detrusor overactivity resulting from a spinal cord injury and/or for idiopathic overactive bladder and urinary incontinence are also described.
Patent CA-3055913-A1 (CA)
Inventor: TSOU ANDY
IPC: C08L23/28
Filed: 2018-01-26
Abstract: Disclosed herein are graft polymers having a copolymer backbone and polycyclic aromatic hydrocarbon branches for use as a nanofiller dispersant and methods for making the same. Also disclosed are elastomeric nanocomposite compositions comprising a halobutyl rubber matrix, nanoparticles of graphite or grapheme, and the graft polymer. Such elastomeric nanocomposite compositions are suitable as tire innerliners or innertubes.
Patent CA-3056517-A1 (CA)
Inventor: JURASZEK JAROSLAW
IPC: C07K16/18
Filed: 2018-03-27
Abstract: The invention relates to binding molecules and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The invention also relates to diagnostic, prophylactic and therapeutic methods using the binding molecules or antigen-binding fragments.
Patent CA-3056707-A1 (CA)
Inventor: CANOVAS VIDAL CARMEN
IPC: G02C7/04
Filed: 2018-03-16
Abstract: Apparatuses, systems and methods for providing improved ophthalmic lenses, particularly intraocular lenses (lOLs). Exemplary diffractive intraocular implants (lOLs) can include a diffractive profile (100) having multiple diffractive zones. The diffractive zones can include a central zone (101) that includes one or more echelettes (102) and a peripheral zone (103) beyond the central zone having one or more peripheral echelettes (104). The central diffractive zone can work in a higher diffractive order than a remainder of the diffractive profile. The combination of the central and peripheral zones and an optional intermediate zone provides a longer depth of focus than a diffractive profile defined just by a peripheral and/or optional intermediate zone.
Patent CA-3057473-A1 (CA)
Inventor: FONG ADAM
IPC: G07F19/00
Filed: 2019-10-03
Abstract: Casino monetary systems and methods of processing casino monetary transactions are configured to read or scan an ID of a customer associated with a monetary value transaction, to transmit that ID information to a remote authentication vendor for authentication, to then use that authentication information as part of a transaction approval process and to create a transaction record, such as relative to an anti-money laundering (AML) system.
Patent CA-3059484-A1 (CA)
Inventor: NGUYEN HOAI-NAM
IPC: F03D7/00
Filed: 2019-10-21
Abstract: La présente invention concerne un procédé de détermination d'un facteur d'induction du vent pour une éolienne (1) équipée d'un capteur LIDAR (2). Pour ce procédé, on réalise des mesures de la vitesse du vent en plusieurs plans de mesure (PM) au moyen du capteur LIDAR (2), puis on détermine des facteurs d'induction entre les plans de mesure (PM) au moyen des mesures et d'un filtre de Kalman linéaire, et on en déduit, au moyen d'un deuxième filtre de Kalman linéaire le facteur d'induction entre un plan de mesure (PM) et le plan du rotor (PR) de l'éolienne (1).
Patent CA-3059734-A1 (CA)
Title: Magnetic resonance imaging (mri) receive coil compatible with mri guided high intensity focused ultrasound (hifu) therapy
Inventor: Lustig Shimon Michael
IPC: A61B5/055
Filed: 2018-04-20
Abstract: Magnetic Resonance Imaging (MRI) receiver coil devices, including a MRI receiver coil or MRI receiver coil arrays, for use in a MRI guided High Intensity Focused Ultrasound system, and methods for manufacturing the same. A MRI receive coil device includes a flexible substrate having a first surface and a second surface opposite the first surface, and a pattern of conductive material formed on one or both of the first and second surfaces, the pattern including at least one receive coil and at least one capacitor, wherein the flexible substrate comprises a dielectric plastic material. In certain aspects, at least one layer of hydrophobic material covers the at least one receive coil and the at least one capacitor.
Patent CA-3061539-A1 (CA)
Inventor: SCHULZE NICOLE
IPC: C11D17/00
Filed: 2017-05-05
Abstract: The invention relates to a preparation containing: (i) a composition containing (a) one, two or a plurality of compounds selected from the group consisting of (a1) alcohol monoterpenes of formula (I) in which R1 is H or methyl, R2 is H or C2-alkenyl, und R3 is a linear or branched, saturated or unsaturated hydrocarbon radical with 4 to 10 carbon atoms, and the enantiomers, diastereomers, racemates, solvates and physiologically compatible salts thereof, and/or (a2) bicyclic epoxy-monoterpenes, (b) at least two lactones of formula (II) in which R4 is H or methyl, R5 is a linear or branched, saturated or unsaturated hydrocabon radical with 2 to 10 hydrocarbon atoms and n is the number 1 or 2, and the enantiomers, diastereomers and racemates thereof, (c) one, two or a plurality of solvents selected from the group consisting of ethanol, water, dipropylene glycol (DPG), diethyl phtalate (DEP), propylene glycol (PG), isopropyl myristate (IPM), isopropyl palmitate (IPP), triethyl citrate (TEC), triacetin (TRI), 1,2-Propanediol, 1,3-Propanediol, Propanethiol, Pentanediol, Hexanediol, Octanediol, Decanediol (SymClariol®), Dodecanol, 4-hydroxy-acetophenone (SymSave® H), glycerine, butylene glycol, pentylene glycol, hexylene glycol, decylene glycol, propylene carbonate, butylene carbonate, glycerine carbonate, 2-5 benzyl heptanol, lauryl alcohol, trimethyl-hydroxypentyl-isobutyrate, glyceryl-caprylate, ethylhexyl glycerine, benzyl benzoate (BB), and optionally (d) other flavouring agents or aromatic substances selected from the group consisting of 3-phenylbutanal (Trifernal), acetyl methyl carbinol, anethole, anisyl acetate, dihydroeugenol, linalyl formate, 2-methyldecanal, 2-benzyl-2-methylbut-3-ene nitrile (Ci- trowanil®B), 3-hexenyl acetate, styrallyl acetate, belanis, citronellal, cinnamyl acetate, rhubafuran, beta-ions, anther, prenyl acetate, 2-phenyl propanal, 4-(4- hydroxyphenyl)butan-2-one (Frambinon®), ethyl phenoxyacetate, isoralderine, gamma-terpinene, limonene, neocyclocitral, methyl lavender ketone, styrallyl propionate, phenyl ethyl propionate, limonenal, 4-isopentylcyclohexanol (Symrose®), 4-methyl-2-phenyl-3,6-dihydro-2H-pyran/4-methylene-2-phenyl-tetrahydropyrane (Rosyrane super), hydrocitronitril, phenoxanol, isoamyl phenylacetate, damascone, silvial, nectaryl, ambroxide, acetyl pyrazine, trimethyl pyrazine, isoamyl acetate, para-cresyl methyl ether, filbertone, cyclohexyl acetate, heliotropin, acetophenone, anisaldehyde, para-methyl acetophenone, veratraldehyde, methyl anisate and vertoprenal; (ii) aldehydes of formula (III) in which R6 is a saturated or non-saturated, linear hydrocarbon radical; and/or (iii) free fatty acids of fomula (IV), in which R7 is a linear or branched, saturated hydrocarbon radical.
Patent CA-3064634-A1 (CA)
Title: Protective approach waic baseband signal transmission
Inventor: NATH PRANAY KANTI
IPC: H04L9/30
Filed: 2019-12-10
Abstract: A transceiver baseband hardware is provided. The transceiver baseband hardware includes a baseband hardware. The baseband hardware includes an encryption-decryption block. The encryption-decryption block encrypts intended transmission data and decrypts encrypted data with key coefficients via a cross logical operation of the encryption-decryption block. The cross logical operation includes when lower significant bytes of the key coefficients operating on most significant bytes of the intended transmission data and the encrypted data.
Patent CA-3065098-A1 (CA)
Title: The mirna-212/132 family as a therapeutic target
Inventor: THUM THOMAS
IPC: A61K31/7088
Filed: 2012-09-06
Abstract: The present invention refers to inhibitors of microRNAs, particularly of microRNAs miR-212 for use in medicine, particularly in the diagnosis, treatment or prevention of cardiac disorders, e.g. cardiac hypertrophy-associated or autophagic disorders, and further refers to isolated nucleic acid molecules, particularly microRNAs miR-212 and related sequences, for use in medicine, particularly human medicine, more particularly in the diagnosis, treatment or prevention of disorders involving cardiac atrophy and/or dysfunctional autophagy, e.g. cardiac cachexia.
Patent CA-3065630-A1 (CA)
Title: Aggrecan binding immunoglobulins
Inventor: STEFFENSEN SOREN
IPC: C07K16/46
Filed: 2018-06-04
Abstract: The present invention relates to immunoglobulins that specifically bind Aggrecan and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of Aggrecan.
Patent CA-3066404-A1 (CA)
Title: Electromechanical linearly actuated electrode
Inventor: RAYMOND ANDREW
IPC: B23K9/067
Filed: 2018-06-14
Abstract: Approaches herein provide a plasma arc torch including a tip surrounding an electrode, the electrode having a proximal end and a distal end, and a shield surrounding the tip, the shield including an exit orifice proximate the distal end of the electrode. The torch may further include a linear actuating device coupled to the electrode for actuating the electrode such that the distal end of the electrode moves axially relative to the tip and the exit orifice of the shield. In some approaches, the linear actuating device is operable to actuate the electrode along a central longitudinal axis extending through the tip. In some approaches, the linear actuating device may include one of: a micro linear drive motor, a micro linear stepper motor, a voice coil, a solenoid coil, and a magnetostrictive actuator. In some approaches, the electrode is actuated during a welding or cutting cycle of the torch.
Patent CA-3066733-A1 (CA)
Inventor: HOTAMISLIGIL GOKHAN S
IPC: A61P3/04
Filed: 2018-06-11
Abstract: L'invention concerne des composés, des compositions et des procédés d'identification de composés qui neutralisent la capacité du 2-arachidonylglycérol (2-AG), un agoniste du récepteur des cannabinoïdes de type 1 (CB1) en complexe avec la protéine de liaison aux lipides adipocytaires (aP2), son partenaire de liaison obligatoire, à agoniser la signalisation CBl dans les tissus périphériques. Des méthodes de traitement d'un trouble associé à une lipogenèse hépatique de novo dérégulée ou anormale et/ou une résistance à l'insuline sélective hépatique par inhibition de la capacité du 2-arachidonylglycérol (2-AG), un agoniste du récepteur des cannabinoïdes de type 1 (CB1) en complexe avec la protéine de liaison aux lipides adipocytaires (aP2), son partenaire de liaison obligatoire, à se lier et à agoniser CB1, sont en outre décrites.
Patent CA-3067291-A1 (CA)
Title: Method and device for producing feedstock in piece form made from metal
Inventor: SCHARF-BERGMANN ROLAND
IPC: B22D17/00
Filed: 2018-04-05
Abstract: The invention relates to a method for producing feedstock in piece form from metal, in particular aluminium and/or aluminium alloys, for a metal-casting installation, in particular aluminium-casting installation, in which scrap parts of metal, in particular of aluminium and/or aluminium alloys, are sorted on the basis of their alloying constituents and/or alloy contents and subsequently, on the basis of an alloy to be produced in the feedstock, the scrap parts are mixed into a composition having a homogeneous distribution of the alloy and fed to a press, in which the scrap parts of the composition are subjected to a pressure that compresses the scrap parts while generating a temperature, wherein, as a result of the application of pressure, the scrap parts are heated up to the transition temperature between solid and liquid of at least some of the scrap parts and/or the alloys and/or alloying constituents thereof before the feedstock is discharged in a specific geometrical form.
Patent CA-3069017-A1 (CA)
Title: Immunostimulatory fusion molecules and uses thereof
Inventor: ANDRESEN THOMAS L
IPC: C12N5/0783
Filed: 2018-07-03
Abstract: Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.
Patent CA-3069804-A1 (CA)
Title: Anti-cd166 antibodies and uses thereof
Inventor: DESNOYERS LUC ROLAND
IPC: C07K16/28
Filed: 2018-07-13
Abstract: The present invention provides, among other things, an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166, compositions including the same, and uses thereof. In certain embodiments, an anti-CD 166 antibody or antigen-binding polypeptide of the present invention binds or is capable of binding all or a portion of an intracellular domain ("ICD") of CD 166. The present invention also includes, among other things, a nucleic acid molecule encoding an antibody or antigen-binding polypeptide that binds or is capable of binding CD 166. In various embodiments, an anti-CD 166 antibody or antigen-binding polypeptide is useful in a method of detecting or treating a condition or disease.
Patent CA-3072023-A1 (CA)
Inventor: HOBSON JONATHAN ANTHONY
IPC: C12Q1/10
Filed: 2018-08-07
Abstract: The present application relates to a method for detecting the presence of carbapenemase- producing Enterobacteriales, Pseudomonas and Ancinetobacter in a sample, comprising; providing a sample suspected of having carbapenemase-producing Enterobacteriales, Pseudomonas or Acinetobacter; reacting the sample with a solution of (7R)-7-[(z)-2-(2- aminothiazol-4-yl)-(Z)-2(methoxyimino)acetamide]-3-(2,4-dinitrostyryl)-3-cephem-4 carboxylic acid) or a salt thereof, and detecting a color change in the reaction medium when carbapenemase-producing Enterobacteriales, Pseudomonas or Acinetobacter are present in the test sample.
Patent CA-3072846-A1 (CA)
Inventor: BURJA ADAM
IPC: C12P7/64
Filed: 2018-07-18
Abstract: La présente invention concerne une méthode de production améliorée de lipides par limitation d'au moins deux sources de nutriment limitant pendant la fermentation des cellules produisant des lipides.
Patent CA-3073469-A1 (CA)
Inventor: HENRY JEROME A
IPC: A61M3/02
Filed: 2018-08-23
Abstract: Components for use in hollow organ irrigation systems are provided, including collapsible and expandable liquid reservoirs, self-supporting liquid containers for liquid reservoirs, and retaining elements for rectal catheters, which may be inflatable or un-inflatable.
Patent CA-3074291-A1 (CA)
Inventor: HERMISTON TERRY
IPC: C12N9/74
Filed: 2018-09-05
Abstract: The present disclosure relates to a method of targeting stems cells, in particular non-apoptotic stem cells, employing a GLA domain, capable of binding surface exposed phosphatidyl serine.
Patent CA-3075246-A1 (CA)
Inventor: BENCHAOUIR RACHID
IPC: A61P39/00
Filed: 2018-09-11
Abstract: The invention relates to the use of Scleritine as an agent for protecting cells against toxic agents, including in particular chemical agents or physical agents. The invention relates to a dermatological and/or cosmetic composition for the skin which protects against toxic agents, characterized in that it comprises Scleritine in at least one excipient or carrier suitable for topical application. The field of the invention relates to the pharmaceutical industry or the cosmetics industry and more specifically for the formulation of pharmaceutical or cosmetic compositions intended for protecting cells against toxic agents.